Treatment of Adipose Tissue and Skin Laxity at the Buttocks by PDLLA, US and RF

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07010796

Enrollment

Registered

2025-06-08

Start date

2025-01-15

Completion date

2025-05-15

Last updated

2025-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Local Fat Deposits

Brief summary

Local body fat and lax skin is treated with a combined approach of PDLLA injections and topical ultrasound and radiofrequency.

Interventions

DEVICEAlma Prime X

Alma Prime x is a platform that provides applicators for radiofrequency and ultrasound.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* adults over 18 years * patients eligible to be treated with radiofrequency and ultrasound * all genders

Exclusion criteria

* patients displaying contraindications for treatment with radiofrequency and ultrasound * pregnancy * immune diseases * active virus infections

Design outcomes

Primary

Measure	Time frame
change of fat deposits	From enrollment to the end of treatment at 2 months

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026